NewGenIvf Group Valuation
| NIVF Stock | 0.81 0.01 1.01% |
Today, the firm appears to be overvalued. NewGenIvf Group secures a last-minute Real Value of USD0.77 per share. The latest price of the firm is USD0.8081. Our model forecasts the value of NewGenIvf Group from analyzing the firm fundamentals such as Profit Margin of 3.81 %, return on equity of 1.61, and Current Valuation of 6 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that NewGenIvf Group's price fluctuation is out of control at this time. Calculation of the real value of NewGenIvf Group is based on 3 months time horizon. Increasing NewGenIvf Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the NewGenIvf stock is determined by what a typical buyer is willing to pay for full or partial control of NewGenIvf Group Limited. Since NewGenIvf Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NewGenIvf Stock. However, NewGenIvf Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.81 | Real 0.77 | Hype 0.56 |
The real value of NewGenIvf Stock, also known as its intrinsic value, is the underlying worth of NewGenIvf Group Company, which is reflected in its stock price. It is based on NewGenIvf Group's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of NewGenIvf Group's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of NewGenIvf Group Limited helps investors to forecast how NewGenIvf stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NewGenIvf Group more accurately as focusing exclusively on NewGenIvf Group's fundamentals will not take into account other important factors: NewGenIvf Group Cash |
|
NewGenIvf Group Total Value Analysis
NewGenIvf Group Limited is now anticipated to have valuation of 6 M with market capitalization of 788.24 K, debt of 3.03 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the NewGenIvf Group fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6 M | 788.24 K | 3.03 M |
NewGenIvf Group Investor Information
The company has price-to-book ratio of 0.03. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NewGenIvf Group recorded earning per share (EPS) of 4195.34. The entity had not issued any dividends in recent years. The firm had 1:3 split on the 26th of January 2026. Based on the analysis of NewGenIvf Group's profitability, liquidity, and operating efficiency, NewGenIvf Group Limited may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.NewGenIvf Group Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. NewGenIvf Group has an asset utilization ratio of 151.86 percent. This implies that the Company is making USD1.52 for each dollar of assets. An increasing asset utilization means that NewGenIvf Group Limited is more efficient with each dollar of assets it utilizes for everyday operations.NewGenIvf Group Profitability Analysis
Considering NewGenIvf Group's profitability and operating efficiency indicators, NewGenIvf Group Limited may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess NewGenIvf Group's ability to earn profits and add value for shareholders.Net Loss | First Reported 2010-12-31 | Previous Quarter -472.5 K | Current Value -448.9 K | Quarterly Volatility 276.2 K |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.23 | 0.3 |
|
| |||||
| Return On Equity | 0.47 | 0.45 |
|
|
For NewGenIvf Group profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NewGenIvf Group to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NewGenIvf Group utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NewGenIvf Group's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NewGenIvf Group over time as well as its relative position and ranking within its peers.
NewGenIvf Group Earnings per Share Projection vs Actual
By analyzing NewGenIvf Group's earnings estimates, investors can diagnose different trends across NewGenIvf Group's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for NewGenIvf Group Limited is based on EPS before non-recurring items and includes expenses related to employee stock options.NewGenIvf Group Ownership Allocation
Roughly 98.79 % of NewGenIvf Group outstanding shares are held by general public with 0.13 pct. owned by insiders and only 1.08 % by institutional investors.NewGenIvf Group Profitability Analysis
The company reported the previous year's revenue of 5.43 M. Net Loss for the year was (474.1 K) with profit before overhead, payroll, taxes, and interest of 970.96 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates NewGenIvf Group's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in NewGenIvf Group and how it compares across the competition.
About NewGenIvf Group Valuation
The stock valuation mechanism determines NewGenIvf Group's current worth on a weekly basis. Our valuation model uses a comparative analysis of NewGenIvf Group. We calculate exposure to NewGenIvf Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of NewGenIvf Group's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.1 M | 1.7 M | |
| Pretax Profit Margin | (0.20) | (0.19) | |
| Operating Profit Margin | (0.25) | (0.23) | |
| Net Loss | (0.10) | (0.11) | |
| Gross Profit Margin | 0.30 | 0.23 |
NewGenIvf Group Growth Indicators
Investing in growth stocks can be very risky. If the company such as NewGenIvf Group does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 113.9 K | |
| Forward Price Earnings | 0.0336 |
NewGenIvf Group Current Valuation Indicators
Valuation refers to the process of determining the present value of NewGenIvf Group Limited and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value NewGenIvf we look at many different elements of the entity such as NewGenIvf's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as NewGenIvf Group, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use NewGenIvf Group's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes NewGenIvf Group's worth.Complementary Tools for NewGenIvf Stock analysis
When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |